Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2518 (LINC02518) is a human long noncoding RNA (lncRNA) that does not code for a protein. Its expression is significantly upregulated in hepatocellular carcinoma (HCC) tumor tissues compared to non-tumor tissues. Elevated levels of LINC02518 in HCC are associated with worse outcomes, such as higher tumor recurrence, metastasis, and shorter overall survival, making it a candidate prognostic biomarker for HCC patients. Its functional role likely involves the regulation of gene expression linked to tumor progression, though the detailed molecular interactions remain to be fully characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2518 (LINC02518).